These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 24548303)
1. IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects. Valle-Mendiola A; Weiss-Steider B; Rocha-Zavaleta L; Soto-Cruz I Cancer Invest; 2014 May; 32(4):115-25. PubMed ID: 24548303 [TBL] [Abstract][Full Text] [Related]
2. Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes. Shatrova AN; Mityushova EV; Vassilieva IO; Aksenov ND; Zenin VV; Nikolsky NN; Marakhova II PLoS One; 2016; 11(12):e0167215. PubMed ID: 27936140 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer. Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523 [TBL] [Abstract][Full Text] [Related]
4. Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation. Ross JA; Cheng H; Nagy ZS; Frost JA; Kirken RA J Biol Chem; 2010 Feb; 285(6):3582-3591. PubMed ID: 19923221 [TBL] [Abstract][Full Text] [Related]
5. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378 [TBL] [Abstract][Full Text] [Related]
6. Curcumin blocks interleukin (IL)-2 signaling in T-lymphocytes by inhibiting IL-2 synthesis, CD25 expression, and IL-2 receptor signaling. Forward NA; Conrad DM; Power Coombs MR; Doucette CD; Furlong SJ; Lin TJ; Hoskin DW Biochem Biophys Res Commun; 2011 Apr; 407(4):801-6. PubMed ID: 21443863 [TBL] [Abstract][Full Text] [Related]
7. Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptors. Haan C; Rolvering C; Raulf F; Kapp M; Drückes P; Thoma G; Behrmann I; Zerwes HG Chem Biol; 2011 Mar; 18(3):314-23. PubMed ID: 21439476 [TBL] [Abstract][Full Text] [Related]
8. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Miyazaki T; Kawahara A; Fujii H; Nakagawa Y; Minami Y; Liu ZJ; Oishi I; Silvennoinen O; Witthuhn BA; Ihle JN Science; 1994 Nov; 266(5187):1045-7. PubMed ID: 7973659 [TBL] [Abstract][Full Text] [Related]
9. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex. Rodriguez G; Ross JA; Nagy ZS; Kirken RA J Biol Chem; 2013 Mar; 288(10):7137-46. PubMed ID: 23341462 [TBL] [Abstract][Full Text] [Related]
10. [The STAT5 signaling in the expression of alpha-subunit of interleukin-2 receptor in human blood lymphocytes]. Mitiushova EV; Shatrova AN; Zenin VV; Aksenov ND; Marakhova II Tsitologiia; 2013; 55(6):421-9. PubMed ID: 25509109 [TBL] [Abstract][Full Text] [Related]
11. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908 [TBL] [Abstract][Full Text] [Related]
12. Piperine blocks interleukin-2-driven cell cycle progression in CTLL-2 T lymphocytes by inhibiting multiple signal transduction pathways. Doucette CD; Greenshields AL; Liwski RS; Hoskin DW Toxicol Lett; 2015 Apr; 234(1):1-12. PubMed ID: 25655587 [TBL] [Abstract][Full Text] [Related]
13. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells. Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754 [TBL] [Abstract][Full Text] [Related]
14. Regulation of interleukin-2 signaling by fatty acids in human lymphocytes. Gorjão R; Hirabara SM; de Lima TM; Cury-Boaventura MF; Curi R J Lipid Res; 2007 Sep; 48(9):2009-19. PubMed ID: 17592174 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-12-anchored exosomes increase cytotoxicity of T lymphocytes by reversing the JAK/STAT pathway impaired by tumor-derived exosomes. Zhang Y; Wu XH; Luo CL; Zhang JM; He BC; Chen G Int J Mol Med; 2010 May; 25(5):695-700. PubMed ID: 20372811 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic analysis of tofacitinib and basiliximab in kidney allograft recipients. Vafadari R; Quaedackers ME; Kho MM; Mol WM; Chan G; Weimar W; Baan CC Transplantation; 2012 Sep; 94(5):465-72. PubMed ID: 22960764 [TBL] [Abstract][Full Text] [Related]
17. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells. Ding Y; Yu A; Tsokos GC; Malek TR J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588 [TBL] [Abstract][Full Text] [Related]
18. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F; Chiarenza A; Goffin V; Kelly PA Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989 [TBL] [Abstract][Full Text] [Related]
19. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Miyazaki T; Takaoka A; Nogueira L; Dikic I; Fujii H; Tsujino S; Mitani Y; Maeda M; Schlessinger J; Taniguchi T Genes Dev; 1998 Mar; 12(6):770-5. PubMed ID: 9512511 [TBL] [Abstract][Full Text] [Related]
20. Ligation of RARgamma inhibits proliferation of phytohaemagglutinin-stimulated T-cells via down-regulating JAK3 protein levels. Ludányi K; Nagy ZS; Alexa M; Reichert U; Michel S; Fésüs L; Szondy Z Immunol Lett; 2005 Apr; 98(1):103-13. PubMed ID: 15790515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]